These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13798560)

  • 41. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
    Nishio R; Shioi T; Sasayama S; Matsumori A
    J Am Coll Cardiol; 2003 Jan; 41(2):340-5. PubMed ID: 12535832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Spectrophotometric and column-chromatographic analysis of ribonucleic acid extracted from suspensions of the brains of mice infected with MM virus exposed to the action of heat].
    Portocală R; Popa L; Morfei A; Lăcătus V; Popescu M
    Stud Cercet Inframicrobiol; 1966; 17(2):117-24. PubMed ID: 4287543
    [No Abstract]   [Full Text] [Related]  

  • 43. Mast cells play a critical role in the pathogenesis of viral myocarditis.
    Higuchi H; Hara M; Yamamoto K; Miyamoto T; Kinoshita M; Yamada T; Uchiyama K; Matsumori A
    Circulation; 2008 Jul; 118(4):363-72. PubMed ID: 18606918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes mellitus-like syndrome in mice infected with encephalomyocarditis virus.
    Craighead JE; Steinke J
    Am J Pathol; 1971 Apr; 63(1):119-34. PubMed ID: 4323473
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of intranasal administration of recombinant murine interferon-gamma on murine acute myocarditis caused by encephalomyocarditis virus.
    Yamamoto N; Shibamori M; Ogura M; Seko Y; Kikuchi M
    Circulation; 1998 Mar; 97(10):1017-23. PubMed ID: 9529271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration of encephalomyocarditis virus pathogenicity due to a mutation at position 100 of VP1.
    Zhu S; Ge X; Gong X; Guo X; Chen Y; Yang H
    Sci China Life Sci; 2011 Jun; 54(6):535-43. PubMed ID: 21706414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses.
    Mann DL
    J Mol Cell Cardiol; 2001 Sep; 33(9):1551-3. PubMed ID: 11549335
    [No Abstract]   [Full Text] [Related]  

  • 48. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes.
    Hirasawa K; Tsutsui S; Takeda M; Mizutani M; Itagaki S; Doi K
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():737-41. PubMed ID: 8627262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
    Matsumori A; Sasayama S
    Eur Heart J; 1995 Dec; 16 Suppl O():140-3. PubMed ID: 8682082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between encephalomyocarditis (EMC) virus and polio-virus in cultured cells. Increase in the number of EMC virus-producing cells.
    Shirman GA; Maslova SV; Gavrilovskaya IN; Agol VI
    Acta Virol; 1972 Mar; 16(2):175. PubMed ID: 4401077
    [No Abstract]   [Full Text] [Related]  

  • 51. [Etiology of encephalomyocarditis in rhesus monkeys].
    Dshikidse EK; Schevtzova SV; Krylova RI; Balaeva EY; Voskanjan NA; Uvarova VI
    Z Versuchstierkd; 1974; 16(2):142-9. PubMed ID: 4368130
    [No Abstract]   [Full Text] [Related]  

  • 52. Variation in serum creatine phosphokinase activity as indicated in two-phase EMC-D virus-induced myocarditis.
    Mizutani M; Hirasawa K; Takeda M; Doi K; Yukawa M; Matsumoto Y; Matsumoto Y; Onodera T
    Exp Anim; 1996 Oct; 45(4):333-8. PubMed ID: 8902496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of viral myocarditis with ribavirin in an animal preparation.
    Matsumori A; Wang H; Abelmann WH; Crumpacker CS
    Circulation; 1985 Apr; 71(4):834-9. PubMed ID: 2982522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of macrophages in the development of encephalomyocarditis (EMC) virus-induced diabetes in mice.
    Hirasawa K; Takeda M; Itagaki S; Doi K
    Exp Anim; 1996 Jan; 45(1):77-80. PubMed ID: 8689584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization.
    Cronin ME; Love LA; Miller FW; McClintock PR; Plotz PH
    J Exp Med; 1988 Nov; 168(5):1639-48. PubMed ID: 2846742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis.
    Kanda T; Takahashi T; Kudo S; Takeda T; Tsugawa H; Takekoshi N
    Life Sci; 2004 Aug; 75(12):1435-47. PubMed ID: 15240179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective role of interleukin-12 in viral myocarditis.
    Shioi T; Matsumori A; Nishio R; Ono K; Kakio T; Sasayama S
    J Mol Cell Cardiol; 1997 Sep; 29(9):2327-34. PubMed ID: 9299356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pathologic anatomy of experimental diseases of small laboratory animals caused by encephalomyocarditis virus (strain EMK-70)].
    Krylova RI; Balaeva EIa; Voskanian NA; Dzhikidze EK; Shevtsova ZV
    Biull Eksp Biol Med; 1977 Sep; 84(9):368-72. PubMed ID: 199295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental encephalomyocarditis virus infection in small laboratory rodents.
    Doi K
    J Comp Pathol; 2011 Jan; 144(1):25-40. PubMed ID: 20594559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis.
    Miyamoto T; Matsumori A; Hwang MW; Nishio R; Ito H; Sasayama S
    J Am Coll Cardiol; 2001 May; 37(6):1713-8. PubMed ID: 11345389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.